Bonds Between Circulating Tumoral ADN (ctDNA) and the Development of Peritoneal Carcinomatosis for Patients Under PIPAC
Clinical trial NCT04766502 · COMPLETED
Trial details
- NCT number
- NCT04766502
- Sponsor
- Institut de Cancérologie de Lorraine
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-11
- Primary completion
- 2024-12-10
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.